Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol add-on therapy for adults with type 1 Gaucher disease with suboptimal response to enzyme replacement therapy
MOH_2018-05-24_002402Phase 2Not yet recruiting
- Sponsor
- פרופ' ארי זימרן
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ambroxol in Gaucher disease type 1 (GD1), sponsored by פרופ' ארי זימרן. Planned start May 2018; status: not yet recruiting.
02
Drugs
ambroxol
03
Conditions
Gaucher disease type 1 (GD1)
Beyond the preview
Go deeper on MOH_2018-05-24_002402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-05-24_002402.